Mentalization Based Treatment - Introductory Group for Male Prisoners With Borderline and/or Antisocial Personality Disorder in Her Majesty's Prison Barlinnie
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Borderline Personality Disorder (BPD)
- Sponsor
- NHS Greater Glasgow and Clyde
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Completion of three MBT-I group cycles
- Last Updated
- 6 years ago
Overview
Brief Summary
Established evidence base with MBT for treatment of Borderline Personality Disorder (BPD) and/or Antisocial Personality Disorder (ASPD). Demographic information of United Kingdom prison population highlights large proportion of offenders with PD. There is no agreed universal approach to treatment of PD within Scottish prisons with large variance across the prison estate. MBT pilots in HMP Edinburgh and HMP Cornton Vale have demonstrated positive findings in female offenders which could be replicated in male populations.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Primary diagnosis of BPD and/or ASPD
- •Co-morbidity with other personality disorder is accepted
- •Sentenced prisoners with estimated date of liberation \> six months
Exclusion Criteria
- •Co-morbid severe and enduring mental illness (schizophrenia, delusional disorder, bipolar affective disorder, major depressive disorder)
- •Co-morbid organic brain disorder (acquired brain injury, alcohol related brain damage)
- •Remand prisoners
- •Uncontrolled substance dependence
- •Index offence of sexual offending
- •Repeatedly chaotic, antisocial or violent behaviour in prison
- •Care in segregation and reintegration unit in past 3 months
- •Current individual specialist psychological therapy in prison
- •English as not first language
Outcomes
Primary Outcomes
Completion of three MBT-I group cycles
Time Frame: 18 months
Participants to have attended ≥75% (9 or more out of 12) of scheduled sessions to consider this successful completion of the programme. ≥50% participants who commenced session one to have completed the intervention as described above to consider the group successful.
Secondary Outcomes
- Quantitative data measuring change in difficulties with interpersonal relationships pre- and post-intervention(21 months)
- Quantitative data measuring change in anxiety symptoms pre- and post-intervention(21 months)
- Quantitative data measuring change in social functioning and satisfaction pre- and post-intervention(21 months)
- Qualitative data from follow up interviews of participants examining understanding of and overall satisfaction of intervention(21 months)
- Quantitative data measuring change in difficulties with impulsivity pre- and post-control(21 months)
- Quantitative data measuring change in depressive symptoms pre- and post-intervention(21 months)
- Quantitative data measuring change in anxiety symptoms pre- and post-control(21 months)
- Quantitative data measuring change in difficulties with reflective functioning pre- and post-intervention(21 months)
- Quantitative data measuring change in difficulties with interpersonal relationships pre- and post-control(21 months)
- Quantitative data measuring change in difficulties with impulsivity pre- and post-intervention(21 months)
- Quantitative data measuring change in difficulties with reflective functioning pre- and post-control(21 months)
- Quantitative data measuring change in depressive symptoms pre- and post-control(21 months)
- Quantitative data measuring change in overall symptoms and functioning pre- and post-intervention(21 months)
- Quantitative data measuring change in overall symptoms and functioning pre- and post-control(21 months)
- Quantitative data from behavioural proxy measures examining change in the number of challenging behaviours pre- and post-intervention(21 months)
- Quantitative data from behavioural proxy measures examining change in the number of challenging behaviours pre- and post-control(21 months)
- Quantitative data measuring change in social functioning and satisfaction pre- and post-control(21 months)